Multivalent Fusion DNA Vaccine against Brucella abortus

Biomed Res Int. 2017:2017:6535479. doi: 10.1155/2017/6535479. Epub 2017 Sep 7.

Abstract

As an alternative brucellosis prevention method, we evaluated the immunogenicity induced by new multivalent DNA vaccines in BALB/c mice. We constructed the vaccines by fusion of BAB1_0273 and/or BAB1_0278 open reading frames (ORFs) from genomic island 3 (GI-3) and the Brucella abortus 2308 sodC gene with a link based on prolines and alanines (pV273-sod, pV278-sod, and pV273-278-sod, resp.). Results show that immunization with all tested multivalent DNA vaccines induced a specific humoral and cellular immune response. These novel multivalent vaccines significantly increased the production of IgM, IgG, and IgG2a antibodies as well as IFN-γ levels and the lymphoproliferative response of splenocytes. Although immunization with these multivalent vaccines induced a typical T-helper 1- (Th1-) dominated immune response, such immunogenicity conferred low protection levels in mice challenged with the B. abortus 2308 pathogenic strain. Our results demonstrated that the expression of BAB1_0273 and/or BABl_0278 antigens conjugated to SOD protein can polarize mice immunity to a Th1-type phenotype, conferring low levels of protection.

MeSH terms

  • Animals
  • Brucella abortus / drug effects
  • Brucella abortus / immunology*
  • Brucella abortus / pathogenicity
  • Brucellosis / genetics
  • Brucellosis / immunology
  • Brucellosis / prevention & control*
  • Disease Models, Animal
  • Genomic Islands / genetics
  • Genomic Islands / immunology
  • Humans
  • Immunity, Cellular / drug effects
  • Mice
  • Superoxide Dismutase / genetics
  • Superoxide Dismutase / immunology
  • Vaccines, DNA / administration & dosage*
  • Vaccines, DNA / immunology

Substances

  • Vaccines, DNA
  • Superoxide Dismutase